Abstract
Restless Legs Syndrome/Willis-Ekbom Disease is a very common disease, characterized by an urge to move the legs associated with dysesthesia when they are at rest, that is relieved by movement and worsens in the evening or during the night, supportive clinical features that are not essential but can help to resolve diagnostic uncertainty. Supportive features include sleep disturbances, family history of RLS, and a positive therapeutic response to dopaminergic medications. Dopamine receptor agonist and α2δ calcium-channel ligands represent the first-choice therapy. Several daytime consequences could occur in patients with RLS/WED and impact daytime functioning such as diurnal symptoms, sleepiness and fatigue, executive dysfunction, and augmentation (that is drug-related exacerbation). Quality of life could be impaired in moderate to severe RLS.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Montplaisir J, Allen RP, Walters A, Ferini-Strambi L (2011) Restless legs syndrome and periodic limb movements during sleep. In: Kryger MH, Roth T, Dement WC (eds) Principles and practice of sleep medicine, 5ed edn. Elsevier Saunders, St Louis, pp 1026–1037
Manconi M, Fulda S (2013) Etiologies of sleep-related movement disorders (SRMD). In: Kushida C (ed) The encyclopedia of sleep, vol 4. Academic Press, Waltham, pp 17–21
Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4:101–119
Manconi M, Ferri R, Zucconi M et al (2007) First night efficacy of pramipexole in restless legs syndrome and periodic leg movements. Sleep Med 8:491–497
Aurora RN, Kristo DA, Bista SR et al (2012) The treatment of restless legs syndrome and periodic limb movement disorder in adults-an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine clinical practice guideline. Sleep 35:1039–1062
Garcia-Borreguero D, Kohnen R, Silber MH et al (2013) The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group. Sleep Med 14:675–684
Kallweit U, Siccoli MM, Poryazova R et al (2009) Excessive daytime sleepiness in idiopathic restless legs syndrome: characteristics and evolution under dopaminergic treatment. Eur Neurol 62:176–179
Fulda S, Szesny N, Ising M et al (2011) Further evidence for executive dysfunction in subjects with RLS from a non-clinical sample. Sleep Med 12:1003–1007
Paulus W, Trenkwalder C (2006) Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome. Lancet Neurol 5:878–886
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Italia
About this chapter
Cite this chapter
Manconi, M., Maestri, M. (2014). Restless Legs Syndrome/Willis-Ekbom Disease. In: Garbarino, S., Nobili, L., Costa, G. (eds) Sleepiness and Human Impact Assessment. Springer, Milano. https://doi.org/10.1007/978-88-470-5388-5_21
Download citation
DOI: https://doi.org/10.1007/978-88-470-5388-5_21
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5387-8
Online ISBN: 978-88-470-5388-5
eBook Packages: MedicineMedicine (R0)